Treatment of original cavitary pulmonary tuberculosis with capreomycin (CM) and para-aminosalicylic acid (PAS).
D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents